CME Learning Objectives: Explain the process by which tissue factor (TF) initiates blood coagulation and is implicated in tumor progression. Describe the proposed mechanisms of targeting TF in malignancy.
Book Title: Tissue Factor as a Novel Target for Treatment of Breast Cancer
Author:
Published on 2013 by
ISBN: /
Total Page:
Book Category:
Book is About: Breast Cancer Treatment
Get Tissue Factor as a Novel Target for Treatment of Breast Cancer eBook
CME Learning Objectives: Explain the process by which tissue factor (TF) initiates blood coagulation and is implicated in tumor progression. Describe the proposed mechanisms of targeting TF in malignancy. Discuss the applications of TF targets in developing new treatments for aggressive cancers including triple‐negative breast cancer. Tissue factor (TF), a 47‐kDa transmembrane glycoprotein that initiates blood coagulation when complexed with factor VIIa (FVIIa), is expressed in several tumor types. TF has been shown to play a role in cell signaling, inflammation, angiogenesis, as well as tumor growth and metastasis. Activation of the TF signaling pathway has been implicated in mediating the function of many tumor cell types and has led to TF as a potential target in the treatment of several malignancies. Formation of the TF‐FVIIa complex in breast cancer cells has been shown to exert an antiapoptotic effect and play a key role in tumor growth and metastasis. Breast cancer growth is suppressed by inhibition of TF‐mediated PAR2 signaling, and deficiency in PAR2 delays spontaneous breast cancer development in mice. TF is expressed in triple‐negative breast cancer (TNBC), an aggressive type of breast cancer in which there is currently a paucity of available targets. Various methods of targeting TF have been investigated and include immunoconjugates or icons, anti‐TF antibodies, TF pathway inhibitors, targeted photodynamic therapy, and microRNAs. These investigations may give way to promising clinical therapies for breast cancer, especially in TNBC, for which there are relatively few effective treatment options. Abstract : Tissue factor (TF) is frequently expressed in a variety of human breast cancer types, including triple‐negative breast cancer. This article examines the usefulness of TF as a target in combating the most aggressive cancers, in which TF is frequently highly expressed.
From the most popular Breast Cancer Treatment Books, Tissue Factor as a Novel Target for Treatment of Breast Cancer is the one of great book to have. You can get ebook from:
There are so many ebooks about Tissue Factor as a Novel Target for Treatment of Breast Cancer that are available to have. Thinking of having Tissue Factor as a Novel Target for Treatment of Breast Cancer ebook? You are in the right place. Get the ebook Tissue Factor as a Novel Target for Treatment of Breast Cancer by: .
- Book was ranked at 31 by Google Books for Tissue Factor as a Novel Target for Treatment of Breast Cancer
- Tissue Factor as a Novel Target for Treatment of Breast Cancer published by since 2013 with ISBNs. The book ISBN 13 Code is and ISBN 10 Code is
- Reading Mode in Text Status is false and Reading Mode in Image Status is false
- The book has " Pages" is Printed at BOOK under Category
- Rated by Raters and have average rate at ""
- eBook Maturity (Adult Book) status is NOT_MATURE
- eBook written in en
- Book Preview Address: http://books.google.com/books?id=P865vQEACAAJ&dq=Breast+Cancer+Treatment&hl=&cd=350&source=gbs_api
Book Preview
- Server 2: SECURE LINK